TY - JOUR
KW - buprenorphine waiver
KW - Medical Education
KW - opioid use disorder
AU - A. Shapiro
AU - L. R. Villarroel
AU - P. George
A1 - 
AB - Physicians who want to prescribe buprenorphine to treat opioid use disorder require a waiver established by the Drug Addiction Treatment Act (DATA) of 2000, often through completion of an eight-hour training course. This is an issue for a number of reasons, including that opioid overdose deaths continue to rise nationally. However, on October 24, 2018, the SUPPORT (Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment) for Patients and Communities Act was signed into law. This bill allows any physician who graduates in good standing from an allopathic or osteopathic medical school in the United States that incorporates necessary material around opioid misuse in their standard curriculum, without need for any additional training, to prescribe buprenorphine. This perspective piece describes why this is an important first step and what more needs to be done within medical education to combat the opioid epidemic.
AD - The Warren Alpert Medical School of Brown University , Providence, RI, USA.; Division of Public Health Preparedness, Arizona Department of Health Services , Phoenix, AZ, USA.; Department of Family Medicine, The Warren Alpert Medical School of Brown University, Providence, RI, USA.; Office of Medical Education, The Warren Alpert Medical School of Brown University, Providence, RI, USA.
BT - Advances in medical education and practice
C5 - Education & Workforce; Healthcare Policy; Opioids & Substance Use
DO - 10.2147/AMEP.S205946
JF - Advances in medical education and practice
LA - eng
M1 - Journal Article
N2 - Physicians who want to prescribe buprenorphine to treat opioid use disorder require a waiver established by the Drug Addiction Treatment Act (DATA) of 2000, often through completion of an eight-hour training course. This is an issue for a number of reasons, including that opioid overdose deaths continue to rise nationally. However, on October 24, 2018, the SUPPORT (Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment) for Patients and Communities Act was signed into law. This bill allows any physician who graduates in good standing from an allopathic or osteopathic medical school in the United States that incorporates necessary material around opioid misuse in their standard curriculum, without need for any additional training, to prescribe buprenorphine. This perspective piece describes why this is an important first step and what more needs to be done within medical education to combat the opioid epidemic.
PY - 2019
SN - 1179-7258; 1179-7258; 1179-7258
SP - 581
EP - 583
EP - 
T1 - A call to maximize impact of the SUPPORT for Patients and Communities Act through standard inclusion of opioid use disorder treatment curricula in medical schools
T2 - Advances in medical education and practice
TI - A call to maximize impact of the SUPPORT for Patients and Communities Act through standard inclusion of opioid use disorder treatment curricula in medical schools
U1 - Education & Workforce; Healthcare Policy; Opioids & Substance Use
U2 - 31447600
U3 - 10.2147/AMEP.S205946
VL - 10
VO - 1179-7258; 1179-7258; 1179-7258
Y1 - 2019
Y2 - Aug 2
ER -